‘The Court of Appeal today handed down its judgment dismissing the appeal of various pharmaceutical companies against an earlier judgment of the Competition Appeal Tribunal (“CAT”) finding that they had no limitation defence to a multi-million pound claim by English and Welsh NHS providers arising out of the “pay for delay” cartel in relation to citalopram, an important first-line treatment for depression routinely prescribed by GPs.’
Monkton Chambers, 23rd May 2025
Source: www.monckton.com
